[对细胞生长抑制剂的耐药性] - Suppr

Suppr

超能文献

[Resistance to cytostatic drugs].

作者信息

Elonen E

机构信息

HYKS:n sisätautien klinikka, hematologian toimiala PL 340 00029 HYKS.

出版信息

Duodecim. 1998;114(13):1319-28.

PMID:11552258

Abstract

摘要

相似文献

[Resistance to cytostatic drugs].

Duodecim. 1998;114(13):1319-28.

Preclinical and clinical experience with cisplatin resistance.

Hematol Oncol Clin North Am. 1995 Apr;9(2):415-29.

DNA topoisomerases and topoisomerase inhibitors.

Pathol Biol (Paris). 1994 Apr;42(4):346-52.

Emerging DNA topisomerase inhibitors as anticancer drugs.

Expert Opin Emerg Drugs. 2004 May;9(1):105-33. doi: 10.1517/eoed.9.1.105.32948.

Topoisomerase II inhibitors.

Cancer Chemother Biol Response Modif. 2001;19:129-47.

Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.

Expert Rev Anticancer Ther. 2007 Oct;7(10):1369-78. doi: 10.1586/14737140.7.10.1369.

The modulation of alkylating agents.

Semin Hematol. 1991 Jul;28(3 Suppl 4):22-4.

[On the novel differentiation-apoptosis inducers in tumor cells].

Tanpakushitsu Kakusan Koso. 1996 Feb;41(2):119-26.

Chemosensitization of solid tumors by modulation of resistance mechanisms.

Curr Opin Investig Drugs. 2002 Apr;3(4):634-40.

Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents.

Cancer Chemother Pharmacol. 2002 Jun;49(6):479-86. doi: 10.1007/s00280-002-0451-5. Epub 2002 Apr 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Resistance to cytostatic drugs].

Duodecim. 1998;114(13):1319-28.

Preclinical and clinical experience with cisplatin resistance.

Hematol Oncol Clin North Am. 1995 Apr;9(2):415-29.

DNA topoisomerases and topoisomerase inhibitors.

Pathol Biol (Paris). 1994 Apr;42(4):346-52.

Emerging DNA topisomerase inhibitors as anticancer drugs.

Expert Opin Emerg Drugs. 2004 May;9(1):105-33. doi: 10.1517/eoed.9.1.105.32948.

Topoisomerase II inhibitors.

Cancer Chemother Biol Response Modif. 2001;19:129-47.

Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.

Expert Rev Anticancer Ther. 2007 Oct;7(10):1369-78. doi: 10.1586/14737140.7.10.1369.

The modulation of alkylating agents.

Semin Hematol. 1991 Jul;28(3 Suppl 4):22-4.

[On the novel differentiation-apoptosis inducers in tumor cells].

Tanpakushitsu Kakusan Koso. 1996 Feb;41(2):119-26.

Chemosensitization of solid tumors by modulation of resistance mechanisms.

Curr Opin Investig Drugs. 2002 Apr;3(4):634-40.

Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents.

Cancer Chemother Pharmacol. 2002 Jun;49(6):479-86. doi: 10.1007/s00280-002-0451-5. Epub 2002 Apr 6.